02.01.2015 Views

Book of abstracts - British Neuroscience Association

Book of abstracts - British Neuroscience Association

Book of abstracts - British Neuroscience Association

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

62.01<br />

Complication outcome and clinical evaluation for the isolated and<br />

combined craniocerebral trauma<br />

Lim L W, Volkodav O V, Molchanov V I<br />

Dept. <strong>of</strong> Psychiatry and Neuropsychology, Division <strong>of</strong> Cellular<br />

<strong>Neuroscience</strong>, Faculty <strong>of</strong> Health, Medicine and Life Sciences,<br />

Universitietssingel 50, 6229ER Maastricht. The Netherlands.<br />

Craniocerebral trauma (CCT) has become a major cause <strong>of</strong> death and<br />

disability worldwide. It usually results from a variety <strong>of</strong> etiologic factors<br />

that significantly affect the cognitive, physical, and psychological<br />

functions. Our objective is to evaluate the clinical diagnostic and<br />

therapeutic method, and the complication outcome in both isolated<br />

and combined CCT. Seventy-eight patients, aged 16-54 with 8%<br />

isolated and 60% combined CCT were investigated at the<br />

neurosurgical intensive-care unit (ICU). Approximately 2% mortality<br />

rates result from the excessive hemorrhage during the moment <strong>of</strong><br />

accidents and eventually lead to cerebral hypoxia/ischemia. It was<br />

estimated that 30% victims suffered with fatal consequences during<br />

the ambulatory transportation to the hospital. The mortality rate in<br />

isolated CCT accounts for 3.3% and the combined CCT consists <strong>of</strong><br />

20.4-35% with Glasgow-coma-scale score <strong>of</strong> 3-5. The reasons <strong>of</strong><br />

death were mainly due to the severe complication in combined CCT<br />

especially caused by pr<strong>of</strong>use hemorrhage and multiple injuries<br />

including thoracic and abdominal trauma and long-bone fractures. The<br />

therapeutic approach covers a wide range <strong>of</strong> critical care measures<br />

including oxygenation and blood pressure, intracranial pressure<br />

monitoring, cerebral perfusion pressure management, nutritional<br />

support, hypertonic solution &amp; mannitol infusion, decompressive<br />

craniotomy, and pharmacological interventions for the severe CCT<br />

patient in the neurosurgical ICU. The treatment <strong>of</strong> CCT requires a<br />

fundamental understanding <strong>of</strong> its pathophysiological changes in the<br />

primary impact and secondary insults that promote excitotoxic<br />

secondary brain damage. It is an obligatory to conduct the initial<br />

resuscitation, elimination <strong>of</strong> cerebral compression, neuro-rehabilitation<br />

and the prevention <strong>of</strong> avoidable complications.<br />

62.02<br />

Complication outcome and clinical evaluation for the isolated and<br />

combined craniocerebral trauma<br />

Lim L W, Volkodav O V, Molchanov V I<br />

Dept. <strong>of</strong> Psychiatry and Neuropsychology, Division <strong>of</strong> Cellular<br />

<strong>Neuroscience</strong>, Faculty <strong>of</strong> Health, Medicine and Life Sciences,<br />

Universitietssingel 50, 6229ER Maastricht. The Netherlands.<br />

Craniocerebral trauma (CCT) has become a major cause <strong>of</strong> death and<br />

disability worldwide. It usually results from a variety <strong>of</strong> etiologic factors that<br />

significantly affect the cognitive, physical, and psychological functions. Our<br />

objective is to evaluate the clinical diagnostic and therapeutic method, and<br />

the complication outcome in both isolated and combined CCT. Seventyeight<br />

patients, aged 16-54 with 8% isolated and 60% combined CCT were<br />

investigated at the neurosurgical intensive-care unit (ICU). Approximately<br />

2% mortality rates result from the excessive hemorrhage during the<br />

moment <strong>of</strong> accidents and eventually lead to cerebral hypoxia/ischemia. It<br />

was estimated that 30% victims suffered with fatal consequences during<br />

the ambulatory transportation to the hospital. The mortality rate in isolated<br />

CCT accounts for 3.3% and the combined CCT consists <strong>of</strong> 20.4-35% with<br />

Glasgow-coma-scale score <strong>of</strong> 3-5. The reasons <strong>of</strong> death were mainly due<br />

to the severe complication in combined CCT especially caused by pr<strong>of</strong>use<br />

hemorrhage and multiple injuries including thoracic and abdominal trauma<br />

and long-bone fractures. The therapeutic approach covers a wide range <strong>of</strong><br />

critical care measures including oxygenation and blood pressure,<br />

intracranial pressure monitoring, cerebral perfusion pressure management,<br />

nutritional support, hypertonic solution and mannitol infusion,<br />

decompressive craniotomy, and pharmacological interventions for the<br />

severe CCT patient in the neurosurgical ICU. The treatment <strong>of</strong> CCT<br />

requires a fundamental understanding <strong>of</strong> its pathophysiological changes in<br />

the primary impact and secondary insults that promote excitotoxic<br />

secondary brain damage. It is an obligatory to conduct the initial<br />

resuscitation, elimination <strong>of</strong> cerebral compression, neuro-rehabilitation and<br />

the prevention <strong>of</strong> avoidable complications.<br />

62.03<br />

Iatrogenic traumatic brain injury: Penetration <strong>of</strong> kirschner’s<br />

knitting needle into the middle cranial cavity<br />

Lim L W, Volkodav O V, Molchanov V I<br />

Dept. <strong>of</strong> Psychiatry and Neuropsychology, Division <strong>of</strong> Cellular<br />

<strong>Neuroscience</strong>, Faculty <strong>of</strong> Health, Medicine and Life Sciences,<br />

Universiteitssingel 50, 6226ER Maastricht. The Netherlands.<br />

Traumatic penetrations <strong>of</strong> foreign objects into the craniocerebral cavity<br />

are <strong>of</strong>ten encountered in the department <strong>of</strong> emergency and<br />

traumatology. A 5-year-old child who was brought to the department <strong>of</strong><br />

pediatric neurosurgery with complains <strong>of</strong> severe headache and<br />

fatigue. On admission, the patient had initial neurological examinations<br />

and radiological scans. The consciousness assessment by Glasgow<br />

Coma Scale was thirteen. Neuroradiological studies revealed a long<br />

hyperdensed object extending from extracranial cavity into the middle<br />

cranial fossa. A thorough history was obtained with attention to how<br />

and when the injury was sustained. Two weeks before the incident,<br />

the child had a blunt trauma <strong>of</strong> mandibular fractures with dislocation <strong>of</strong><br />

the temporomandibular joint. Maxillomandibular surgery was<br />

performed with a Kirschner’s knitting needle to fixate the<br />

temporomandibular articulation and simple interdental ligatures for<br />

mandibular fracture stabilization. The present radiological film<br />

suggested that the mandibular fracture was not properly fixated which<br />

allowing the mobilization <strong>of</strong> Kirschner’s needle moving either<br />

externally or internally. A standard pterional access with Frontotemporo-shpenoidal<br />

approach was performed according to the method<br />

<strong>of</strong> M.G.Yasargil and Oikawa-Miyazawa; followed by an extradural<br />

approach method <strong>of</strong> V.V.Dolenc to the middle cranial structure at the<br />

skull base. Several stages <strong>of</strong> hemostasis were carried out with<br />

electrohemocoagulation on the penetrated Kirschner’s needle during<br />

the needle extracting process at the extradural space <strong>of</strong> middle cranial<br />

fossa. Two weeks after post-operation, CT scan revealed the<br />

supratentorial and middle-craniocerebral structures were in<br />

symmetrical localization. The patient was free <strong>of</strong> neurological deficits<br />

and no signs <strong>of</strong> excessive CSF volume formation.<br />

63.01<br />

Testing for the presence <strong>of</strong> viral infection in Multiple Sclerosis using a<br />

new human panviral diagnostic array.<br />

Trillo-Pazos G, Khan A, Kellam P, Reynolds R, Bell J, Weiss R, Miller D<br />

University College London , Institute <strong>of</strong> Neurology, Dept Of<br />

Neuroinflammation and Windeyer Institute, Division <strong>of</strong> Infection <strong>of</strong><br />

Immunity, London W1T 4JF<br />

MS is a neuroinflammatory disorder characterised by microgliosis, gliosis,<br />

neuronal damage and multifocal demyelinated plaques. Clinically, MS<br />

manifests with motor and cognitive neurological impairments. MS has being<br />

associated with a specific HLA-DR2 phenotype and a putative viral<br />

aetiology based on epidemiological evidence. Over the last 30 years<br />

numerous viruses have being associated with MS, currently EBV, HHV6<br />

and endogenous retroviruses have being implicated in MS.<br />

We have developed a Human Panviral Diagnostic Array (HVDA) to detect<br />

viruses in primary and secondary progressive MS post-mortem tissue<br />

lysates from the basal ganglia and cortical regions <strong>of</strong> the brain.<br />

Histologically these cases have active and chronic plaques as<br />

characterised by immunocytochemistry to different cellular antigens.<br />

Panviral arrays designed to date are based on the detection <strong>of</strong> structural<br />

viral genes that are predominantly expressed in lytic/acute viral infection. It<br />

is likely that MS, if viral in aetiology, is associated with latent and chronic<br />

infection. We designed the HVDA using a biology based approach with<br />

probes to regulatory, replicator and structural genes corresponding to 210<br />

Human viral genomes from 25 different viral families. These arrays were<br />

validated by using cell culture lysates from known viral infections (HIV-1,<br />

EBV, KSHV, HHV6). We detected different patterns <strong>of</strong> viral gene<br />

expression in latent versus lytic infection in 10, 000 to 100 cells infected<br />

with HIV-1 or EBV using our HVDA. To conclude, we have designed and<br />

validated a Human Panviral array to test for the presence <strong>of</strong> viruses MS<br />

and other brain diseases ex vivo.<br />

Page 92/101 - 10/05/2013 - 11:11:03

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!